NCT00411528 2020-12-17Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate CancerNovartisPhase 2 Completed185 enrolled
NCT00035113 2017-02-09EPO906 Therapy in Patients With Prostate CancerNovartisPhase 2 Completed48 enrolled
NCT00035243 2012-04-17EPO906 Therapy in Patients With Advanced Kidney CancerNovartisPhase 2 Completed53 enrolled
NCT00407251 2010-11-05Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel ChemotherapyBritish Columbia Cancer AgencyPhase 2 Completed73 enrolled